Retatrutide is being called the future of weight loss, but what makes it so different from Ozempic and tirzepatide? In this episode, we break down exactly how retatrutide works as a powerful triple agonist targeting GLP-1, GIP, and glucagon, and why early research is showing jaw-dropping fat loss results that may rival bariatric surgery. We cover the science, benefits, potential side effects, and what this breakthrough could mean for the future of obesity and metabolic health.